← Leaderboards
Jed Noah Lampe
University Of Colorado Denver
$4,781,405
Attributed
$4,989,303
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2018–25$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,989,303 · 5
By mechanism
R01$4,573,507 · 4
R21$415,796 · 1
Top collaborators
Most similar at University Of Colorado Denver
Same institution · by research overlap
- Daniel L Gustafson$3,654,915
- Andrew P Fontenot$19,585,312
- Thomas Douglas Nolin$1,808,869
- Linda S Cook$4,558,506
- Christina L Aquilante$985,382
Others in their field
Other Emerging Leaders on “Metabolic”
- Xinhua Li · Nano Terra, Inc.$29,991,620
- Barbara Halina Braffett · George Washington University$22,016,904
- Ionut Bebu · George Washington University$18,816,779
- Jeremy James Martinson · University Of Pittsburgh At Pittsburgh$15,459,738
- Rainer Lohmann · University Of Rhode Island$14,400,221
- Leigh A Johnson · University Of North Texas Hlth Sci Ctr$14,236,023
Research focus
MetabolicPublic HealthUnited States National Institutes Of HealthEnzymesAchievementCytochrome P450Pharmaceutical PreparationsToxic EffectReportingDrug DispositionProductionPediatric PatientsPharmacokinetic ModelPhysiologicalNeonateNovel TherapeuticsLiverHepatotoxicityInfantCyp3a4 GeneIn VitroLifeAffectDrug Metabolism
Grant awards (11)
Impact of Pseudomonas aeruginosa cytochrome P450 enzymes and secondary metabolites on drug metabolism and disposition in the cystic fibrosis patient$678,232
R01 · FY2025 · AI · contact PI
Understanding the underlying toxicological mechanisms of drug-hormone interactions to improve the safety profile of antiviral medications in pregnant people, developing fetuses, and neonates$554,627
R01 · FY2025 · AI · contact PI
Impact of Pseudomonas aeruginosa cytochrome P450 enzymes and secondary metabolites on drug metabolism and disposition in the cystic fibrosis patient$692,070
R01 · FY2024 · AI · contact PI
Understanding the underlying toxicological mechanisms of drug-hormone interactions to improve the safety profile of antiviral medications in pregnant people, developing fetuses, and neonates$631,055
R01 · FY2024 · AI · contact PI
Perfluoroalkanoate (PFAS) modulation of the inflammatory response through potent inhibition of arachidonic acid metabolizing cyclooxygenase and cytochrome P450 enzymes$227,248
R21 · FY2023 · ES · contact PI
The role of CYP3A7 in the disposition and toxicity of HIV inhibitors in the developing infant$399,924
R01 · FY2022 · AI · contact PI
Perfluoroalkanoate (PFAS) modulation of the inflammatory response through potent inhibition of arachidonic acid metabolizing cyclooxygenase and cytochrome P450 enzymes$188,548
R21 · FY2022 · ES · contact PI
The role of CYP3A7 in the disposition and toxicity of HIV inhibitors in the developing infant$399,497
R01 · FY2021 · AI · contact PI
The role of CYP3A7 in the disposition and toxicity of HIV inhibitors in the developing infant$399,087
R01 · FY2020 · AI · contact PI
The role of CYP3A7 in the disposition and Toxicity of HIV inhibitors in the developing infant$412,568
R01 · FY2019 · GM · contact PI
The role of CYP3A7 in the disposition and toxicity of HIV inhibitors in the developing infant$406,447
R01 · FY2018 · GM · contact PI